The formation and properties of the heterobridged complexes [Ir2(µ-pz)(µ-SBut)(cod)2](1)(cod = cyclo-octa-1,5-diene, pz = pyrazolate) and [Ir2(µ-pz)(µ-SBut)(CO)2{P(OMe)3}2](2) are reported. Compound (2) undergoes stepwise addition of molecular iodine to yield the complexes [Ir2(µ-pz)(µ-SBut)In;(CO)2{P(OMe)3}2][n= 2 (3) and 4 (4)]. Interaction of complex (2) with dimethyl acetylenedicarboxylate affords the triply heterobridged complex [Ir2(µ-pz)(µ-SBut)(µ-MeO2CCCCO2Me)(CO)2{P(OMe)3}2](5). Compound (5) undergoes a further oxidative addition with I2 to form [Ir2(µ-pz)(µ-SBut)(µ-MeO2CCCCO2Me)I2(CO)2{P(OMe)3}2](6). Compound (6) can be also obtained using mercury(II) iodide as oxidant, and similarly, [Ir2(µ-pz)(µ-SBut)(µ-MeO2CCCCO2Me)Cl2(CO)2{P(OMe)3}2](7) using mercury(II) chloride. The structures of (5) and (6) have been determined by X-ray diffraction methods. Crystals of (5) are monoclinic, space group P21/n, with a= 18.040(7), b= 15.986(6), c= 11.085(4)Å, β= 92.68(2)°, and Z= 4. Complex (6) is orthorhombic, space group P212121 with a= 13.522(5), b= 20.871 (8), c= 12.649(7)Å, with Z= 4. Both complexes are binuclear with the metal atoms held in proximity by a triple bridge: a pyrazolate anion, a ButS group and a dimethyl acetylenedicarboxylate ligand bonded as a cis-dimetallated olefin. The oxidative addition of I2 to (5) originates a remarkable change in the Ir–Ir distance from 2.614(2) to 3.626(2)Å, leaving practically unaltered the bridging framework.
No takes yet. Share an insight, caveat, or question.
Pinillos et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: